Newsroom

Location: ePoster Section - Exhibit Hall
Monitor: 11
Dates:Friday, November 10th
Time: 3:45 - 4:00 PM (PT)

Posters:

Impact of Angioedema on the Pharmacokinetics of Epinephrine Following Administration via Sublingual Film

Abstract ID: 8053
ePoster ID: P004
Presentation Time: Friday, November 10th 3:45 - 4:00 PM (PT)

Location: ePoster Section - Exhibit Hall
Monitor: 11
Date: Friday, November 10th
Time: 3:45 - 4:00 PM (PT)

Posters:

Epinephrine Administered via Sublingual Film, Manual Injection, or Auto-Injectors in Healthy Adults: Pharmacodynamic Results

Abstract ID:8052
ePoster ID: P005
Presentation Time:Friday, November 10th 4:00 - 4:15 PM (PT)

Location: San Antonio, TX

Dates: February 24-27, 2023

Posters:

EPIPHAST Part 3 AAAAI 2023 Oppenheimer final

Poster Title:  IMPACT OF FOOD EXPOSURE ON THE PHARMACOKINETICS OF EPINEPHRINE SUBLINGUAL FILM
Poster Number: 7
Presentation Time: Friday February 24^th 3:15-4:15 PM
Lead Author: John Oppenheimer, M.D., UMDNJ Rutgers University School of Medicine

EPIPHAST Part 3 AAAAI 2023 Bernstein final

Poster Title:   PHARMACOKINETICS OF EPINEPHRINE SUBLINGUAL FILM FOLLOWING THREE DIFFERENT ADMINISTRATION PROCEDURES
Poster Number: 17
Presentation Time: Friday February 24^th 3:15-4:15 PM
Lead Author: David Bernstein M.D., University of Cincinnati College of Medicine

EPIPHAST Part 2 AAAAI 2023 Golden final

Poster Title:  PHARMACOKINETICS AND PHARMACODYNAMICS OF EPINEPHRINE SUBLINGUAL FILM VERSUS INTRA-MUSCULAR EPINEPHRINE
Poster Number: 12
Presentation Time: Friday February 24^th 3:15-4:15 PM
Lead Author: David Golden M.D., Medstar Franklin Square Hospital

EPIPHAST II AAAAI 2023 Greenhawt final

Poster Title:   COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF EPINEPHRINE DELIVERED BY A SUBLINGUALLY ABSORBED FILM VERSUS 0.3 MG ADMINISTERED BY A STANDARD IM INJECTION OR THE EPIPEN®
Poster Number: L13
Presentation Time: Friday February 24^th 3:15-4:15 PM
Lead Author: Matthew Greenhawt, M.D., MBA, MSc, Children's Hospital Colorado

Location: Virtual

Dates: November 30-December 1

Available for investor meetings on Thursday, December 1st

Location: New York, NY

Dates: November 29-December 1

Presentation: Wednesday, November 30^th at 1:50 pm ET

Location: Louisville, KY

Dates: November 10-14

Poster Details:

Abstract Title: Pharmacokinetics Study of Epinephrine Sublingual Film: Results from The Formulation and Dosage Selection
Presenting Author: Dr. John Oppenheimer, MD (UMDNJ Rutgers University School of Medicine)

Abstract Title: Minimal Impact of Food, Drink, Or Temperature on The Pharmacokinetics of a Sublingual Film Using a Novel Prodrug of Epinephrine (DESF)
Presenting Author: Holly Ponichtera, PhD (Aquestive Therapeutics)

Abstract Title: Results of a Repeat Dose Study on The Pharmacokinetics of a Sublingual Film using a Novel Prodrug of Epinephrine (DESF)
Presenting Author: Holly Ponichtera, PhD (Aquestive Therapeutics)

Location: Phoenix, AZ

Dates: February 25-28

Poster: (L37) A Phase 1, Randomized Study Evaluating the Safety Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single Ascending Doses of Epinephrine Prodrug 109 Sublingual Film (AQST-109) in Healthy Male Volunteers

• Room: Convention Center, North Building, Lower Level, Hall 4
• Date: 2/28/2022, 9:45 am - 10:45 am
• Convention Center, North Building, Lower Level, Hall 4

Location: Baltimore, MD
Dates: December 6 - December 10, 2019
Booths: #344 and #547

Location: Charlotte, NC
Dates: October 23 - October 26, 2019
Booths: #820 and #821

Location:  New Orleans, LA
Dates:  November 30 - December 4, 2018

Location:  Boca Raton, FL
Dates:  November 1-4, 2018

Location:  Chicago, IL
Dates:  October 15-18, 2018

Location:  San Francisco, CA
Dates:  September 10-11, 2018

Location:  Boston, MA
Dates:  September 5-6, 2018

Location:  Boston, MA
Dates:  June 4-7, 2018

Location: Los Angeles, CA
Dates: April 21-27, 2018

Location:  San Diego, CA
Dates:  March 17-20, 2018

Location:  Rockville, MD
Dates:  March 7-10, 2018

Location:  San Francisco, CA
Dates:  February 22-23, 2018

Location: Palm Beach Gardens, FL
Dates: January 22-24, 2018

Mark Schobel, Chief Innovation & Technology Officer, participated in a panel discussion titled “Oral Thin Films from Development to Commercialization”

Location:  San Francisco, CA
Dates: January 8-10, 2018

Location: San Francisco, CA
Dates: January 8-11, 2018

Location: Boston, MA
Dates: December 8-10, 2017

Location: Washington, D.C.
Dates: December 1-5, 2017

Location: Laguna Niguel, CA
Dates: October 23–25, 2017

Location: Boston, MA
Dates: October 19–20, 2017

Location: Boston, MA
Dates: September 26–27, 2017

Location: Boston, MA
Dates: August 28–29, 2017